Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. - Wikidata - awgldk - TriplyDB

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.

http://www.wikidata.org/entity/Q34573662

about

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity Diabetic cardiomyopathy: signaling defects and therapeutic approaches Potent PPARα activator derived from tomato juice, 13-oxo-9,11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Suggestion for linkage of chromosome 1p35.2 and 3q28 to plasma adiponectin concentrations in the GOLDN Study Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes.Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway.New insight into adiponectin role in obesity and obesity-related diseases.Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Adiponectin provides cardiovascular protection in metabolic syndrome.Pharmacological and non-pharmacological interventions to influence adipose tissue function.Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes Pharmacological effects of lipid-lowering drugs on circulating adipokines.Energy intake and adiponectin gene expression.Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity.The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.Adiponectin and cardiovascular health: an update Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Adiponectin in pulmonary disease and critically ill patients.Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity.Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.Undaria pinnatifida and Fucoxanthin Ameliorate Lipogenesis and Markers of Both Inflammation and Cardiovascular Dysfunction in an Animal Model of Diet-Induced Obesity.Adiponectin inhibits allograft rejection in murine cardiac transplantation.A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.Adiponectin and energy homeostasis.Adiponectin and lipoprotein metabolism.Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass.Can Adiponectin Help us to Target Diastolic Dysfunction?Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting."The metabolic syndrome... is dead": these reports are an exaggeration.Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue.Fenofibrate increases serum vaspin by upregulating its expression in adipose tissue.Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot study.

P2860

Q21246041-BFD09ACD-E7FA-4C77-B924-E828B61808CC Q27322096-F867BCA8-F392-4C2D-8054-FC70687FDDFF Q28395852-A4802AEA-802C-4871-8B71-5790BDD6014E Q28732165-EC927C69-7449-47CC-B092-C39BEA270BBF Q30241952-71ADCD46-9A07-473B-86EC-ACA0BED32149 Q33441945-BC304C48-E11B-4BBA-B30E-7F47BAE4662C Q33628211-F2EC3F5F-00CB-4624-9C16-15D2843B7D3B Q33642616-77936844-5C21-490A-BC2F-5B3F84BCC7BB Q33943727-A3355F1A-85BA-4BD1-A966-588757FC309E Q34362340-781A16B3-5364-4BE2-B529-CDF393535590 Q34501403-AC1BB903-C31F-4DEB-BCAB-BEEBC956CAD9 Q34557564-6A4DA5E9-C482-4A9E-9A4E-99823F8AFF3B Q34576535-5D70B352-18CF-4D3B-9440-83B6F89C629E Q34656848-D879A6EB-7541-40E1-BBF7-516DA44EEEC9 Q34776235-AB85A5DE-10EE-44BF-B27E-A6B2651D0B2C Q34877922-00B75C12-49B5-44B9-823A-5D4AD8A53FC8 Q34979370-1553C47C-D140-436A-A9FE-FC798FEAF8B3 Q35018311-FD277513-6426-4451-8AFF-647ADC9D7BFC Q35132445-317AED17-F99C-4E2D-9CBB-FCFD6E222D8C Q35304374-9861BA7F-2E46-49D8-832D-012012703095 Q35859734-EB4A315B-20DB-4633-BE9C-D3C345439EE7 Q36411656-CA88EA50-8F01-4C4C-A93C-6DD2983E8EDA Q36714296-F9101F03-D32B-4D91-B172-0CE967EFE26E Q36972569-DE4BBF9F-7C12-4A2E-9324-C77C20AACBD7 Q37190372-2BB0D99F-D3B6-4987-9B16-432E003FB721 Q37209188-52DE6897-8098-4F58-A308-06D4CC39796F Q37444222-FBC7E2F5-C6D3-4689-921A-1186A8A23FF3 Q37556648-ADC30EB1-CF84-48E9-912C-633901455D5F Q37735581-D066A2D0-CE6D-458B-B2A4-ED32422D6276 Q38129920-415602A3-B1A3-4B37-A579-82DC7F7B5465 Q38136560-4D4EF75D-BD4D-41B4-BCEA-A795A45C07DF Q38267491-87EE918E-3827-4325-8C54-F7AE1BFEEFEE Q38353803-5DACF3DE-EBFF-442A-9A15-822CFD5A67CE Q38984959-748B0299-674D-41BC-81E1-53CD4CE36CAA Q42153233-C89C578D-E898-4DAB-9F0B-BB5A4A68DC89 Q42593443-03F6E7AA-8616-4BB1-AB04-5B4D6B8919D6 Q42805021-4AEEB4FA-13E0-4A61-B3E1-21A8A0C1AEBC Q42815380-6D7CBDA3-7631-4BE6-857C-E611E90247E9 Q42818117-51A408D2-16E2-4D8E-A52C-385596146C3E Q43238409-DAF22CFF-F188-42FE-8805-3E88BA6E6612

P2860

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.

http://www.wikidata.org/entity/Q34573662

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@ast

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@en

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@nl

type

label

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@ast

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@en

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@nl

prefLabel

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@ast

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@en

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@nl

P1433

Q34573662-7BFEFE0E-5EE3-47DA-AD3A-966F349EAB2C

P1476

Q34573662-E9429452-0AD0-4842-9C5C-EFD35585B11A

P2093

Q34573662-1BB3EF55-5D9D-4B68-9D70-0F4F2DDB8836

Q34573662-32E6905A-AD76-4241-9BFC-80D78AD18EBC

Q34573662-376A811D-8CC0-4079-90D2-1B179129D5F1

Q34573662-4675C371-3C14-43EE-97C1-885483E28478

Q34573662-48D4021B-3C82-4988-8370-DE14780FEADD

Q34573662-4B878658-CB80-4E0F-85B8-5AF51A0A8869

Q34573662-55E9D011-E3DF-4BBA-87C7-FDE2990D1C80

Q34573662-6A6D0F04-B50D-40ED-80E4-CA3B08D71E55

Q34573662-77DC691F-F6CE-4028-8525-55D03116D47B

Q34573662-8B80A716-DAEA-49AC-9D26-0B686BDB3C13

P304

Q34573662-494E30C2-36FA-4D3C-B5AF-7FE9EE850350

P31

Q34573662-DF016719-E0B6-41CE-BB11-488CD892805B

P356

Q34573662-A65A7DCE-48E1-400F-A156-1EBB6A9D0BFF

P407

Q34573662-18B564F1-6E20-40F2-AC9C-06D89B6A40C2

P433

Q34573662-F684F7D1-B561-47FD-AA55-6E794CCD02AF

P478

Q34573662-DD8B35C3-82BF-47DA-93C6-4498FCA7C495

P50

Q34573662-839F2D23-BEFC-46E4-AD0D-1DEC6DB468AE

P577

Q34573662-4E7C6E75-8106-42EA-97E4-D490A7A1E7CD

P698

Q34573662-66EDC3EF-2EC4-4B62-B679-F8BA54959D21

P356

01.ATV.0000256469.06782.D5

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Effects of peroxisome prolifer ...... fibrate, on adiponectin level.

@en

P2093

Aki Hiuge

http://www.w3.org/2001/XMLSchema#string

Alexander Tenenbaum

http://www.w3.org/2001/XMLSchema#string

David Tanne

http://www.w3.org/2001/XMLSchema#string

Enrique Z Fisman

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nishizawa

http://www.w3.org/2001/XMLSchema#string

Iichiro Shimomura

http://www.w3.org/2001/XMLSchema#string

Koichi Fujita

http://www.w3.org/2001/XMLSchema#string

Masahiro Kumada

http://www.w3.org/2001/XMLSchema#string

Michael Motro

http://www.w3.org/2001/XMLSchema#string

Michal Benderly

http://www.w3.org/2001/XMLSchema#string

P304

635-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000256469.06782.D5

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17194889

http://www.w3.org/2001/XMLSchema#string